Home » Health Care

Press Releases

2012 BIO International Convention to Highlight the FDA and Regulatory Environment
May 9 2012

Global event for biotechnology to be held June 18-21, 2012 in Boston.

BIO Testifies on Importance of Timely Passage of BsUFA and PDUFA
March 29 2012

Sara Radcliffe, Executive Vice President of Health at the Biotechnology Industry Organization...

BIO Testifies on Importance of Prompt Enactment of PDUFA V Recommendations
February 1 2012

In the testimony, Richard Pops, Alkermes plc Chairman and CEO,  stressed the...

BIO Urges Congress to Promptly Reauthorize PDUFA to Promote the Development of Innovative Therapies and Speed New Medicines to Patients
January 13 2012

BIO strongly supports the PDUFA V recommendations as they will enhance the drug development...

BIO Expresses Strong Support for Timely Reauthorization of PDUFA
October 24 2011

In a public meeting hosted by FDA, BIO  expressed strong support for the PDUFA V...

BIO Supports Timely Reauthorization of PDUFA to Promote the Development of Innovative Therapies and Speed New Medicines to Patients
September 1 2011

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

BIO Celebrates Senate Passage of PDUFA Reauthorization Package
September 21 2007

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

BIO Commends House for Approving PDUFA Reauthorization Package
September 19 2007

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

Recommended Improvements to Prescription Drug User Fee Program Will Improve Drug Safety
January 11 2007

The recommended improvements to the Prescription Drug User Fee Act (PDUFA) announced today by...

House Passes Bioterrorism/PDUFA Legislation in 425-1 Vote
May 22 2002

The House of Representatives today voted 425-1 to approve “The Public Health Security...

BIO President Addresses FDA on PDUFA
September 18 2000

Letters, Testimony & Comments

BIO's Suppport for the Reauthorization of the Prescription Drug User Fee Act (PDUFA V)
May 10 2012
    Dear Chairman Upton and Ranking Member Waxman: On behalf of the Biotechnology Industry Organization (BIO), I am...
BIO Endorsement Letter for the Senate Health, Education, Labor and Pensions Committee Markup of the Food and Drug Administration Safety and Innovation Act (FDASIA)
May 2 2012
      On behalf of the Biotechnology Industry Organization (BIO), I am writing to express support for the Food...
BIO's Testimony to the April 18, 2012 House Committee on Energy and Commerce, Subcommittee on Health Hearing on "FDA User Fees 2012: How Innovation Helps Patients and Jobs"
April 18 2012
Chairman Upton and Pitts, Ranking Member Waxman and Pallone, Members of the Committee, it is my privilege to provide testimony before you...
BIO's Testimony to the Senate Health, Education, Labor, and Pensions Full Committee Hearing on the FY2012 FDA User Fee Agreements
March 29 2012
 Chairman Harkin, Ranking Member Enzi, Members of the Committee, it is my privilege to provide testimony before you today. My name...
PDUFA V: Testimony to House Committee on Energy and Commerce, Subcommittee on Health
February 1 2012
  Chairmen Upton and Pitts, and Ranking Members Waxman and Pallone, it is my privilege to provide testimony before this...
More Letters, Testimony & Comments →

Press Releases

2012 BIO International Convention to Highlight the FDA and Regulatory Environment
May 9 2012
WASHINGTON, DC – (May 9, 2012) – The U.S. regulatory environment strongly impacts innovation and the...
BIO Testifies on Importance of Timely Passage of BsUFA and PDUFA
March 29 2012
Washington, D.C. (March 29, 2012) – Sara Radcliffe, Executive Vice President of Health at the Biotechnology...
BIO Testifies on Importance of Prompt Enactment of PDUFA V Recommendations
February 1 2012
Washington, D.C. (February 1, 2012) – Richard Pops, Chairman and CEO of Alkermes plc, testified today on behalf...
BIO Urges Congress to Promptly Reauthorize PDUFA to Promote the Development of Innovative Therapies and Speed New Medicines to Patients
January 13 2012
Washington, DC (January 13, 2012)- Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released...
BIO Expresses Strong Support for Timely Reauthorization of PDUFA
October 24 2011
Washington, D.C. (October 24, 2011) – The Biotechnology Industry Organization (BIO) provided a statement of...
More Press Releases →